New cancer drug has proven safe and effective for pediatric patients with a rare tumor gene mutation. This drug is called larotrectinib (LOXO-195), its safety has been tested on pediatric patients with a mutation known as tropomyosin receptor kinases (TRK).
from Medindia Health News https://ift.tt/2Iogflb
No comments:
Post a Comment